Buying Lilly’s own medicines, straight from Lilly
LillyDirect sells Eli Lilly’s brand-name drugs to cash-paying patients at prices printed on the page, and that openness is the strongest reason to use it. What you buy is a price and a dispensing route, not a care team. Lilly employs no clinicians in this model: your own doctor can send the prescription, or you can use an independent telehealth service the site points you toward. Self-pay listings run from $35 a month for Humalog and $149 for Foundayo, up to $299 to $449 for a one-month supply of Zepbound, with no platform membership fee stacked on top. The trade is real: no insurance billing, no labs or dose coaching inside the price, and refills that run through third-party pharmacy portals rather than one phone line at Lilly.
What the cash prices cover, and what sits outside them
Priced per medicine, never per plan
The model is pharma-direct. Each medicine carries its own self-pay figure for a one-month supply, and no subscription wraps around them. Zepbound is listed at $299 to $449 a month on self-pay, Foundayo from $149, and Humalog from $35. Because the manufacturer sets those numbers itself, there is unusually little guesswork before you reach a cart.
The Zepbound band matters more than its low end. Confirm which strength the $299 figure buys before you commit, because moving up a dose can shift your monthly spend by well over a hundred dollars. Prices on manufacturer storefronts move with commercial strategy, so treat any figure you read anywhere, including ours, as a prompt to confirm on the official LillyDirect site before you pay.
The costs the sticker leaves out
This LillyDirect review treats the published medicine price as the honest headline, not the total. Budget separately for:
- The clinician who writes and renews the prescription, whether that is your own doctor or an independent telehealth partner.
- Baseline and follow-up labs, which many prescribers want before and during treatment with an incretin medicine.
- Coaching, nutrition support or any habit program you want alongside the drug.
- Anything outside Lilly’s own catalogue, since a switch to another manufacturer’s product means leaving this route entirely.
Insurance, deductibles and the cash-pay maths
Insurance is not billed here. You pay the listed cash price with a card, which means the spend may never touch your deductible or out-of-pocket maximum. If you have drug coverage, price the same medicine through your plan first, then compare. Medicare rules in particular treat manufacturer cash programs differently from covered drugs, so read the coverage rules at Medicare.gov before you assume cash is cheaper over a year.
Ask your plan administrator whether an HSA or FSA card works for the purchase, since that answer varies by plan. Our Free Cost Calculators can hold both numbers side by side while you decide.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
Zepbound: the track most people arrive for
What tirzepatide actually does
Zepbound is tirzepatide, a once-weekly injection that acts on two gut hormone receptors, GIP and GLP-1. It slows stomach emptying and reduces appetite signals, which is why most people eat less on it. The FDA approved it for chronic weight management in adults with obesity, or overweight plus a weight-related condition, alongside a reduced-calorie diet and more physical activity, as described in the agency’s FDA approval announcement. It has since also been cleared for moderate to severe obstructive sleep apnea in adults with obesity.
Trial evidence is strong for weight change. In the 72-week SURMOUNT-1 study of adults with obesity, average weight reduction ran roughly 15% to 21% of body weight depending on dose, against a small change on placebo, per the SURMOUNT-1 trial report. Trial conditions included structured lifestyle support, which this purchase route does not include.
Dosing and titration, and who manages it
The approved labelling starts adults at 2.5 mg once weekly for four weeks, then steps up in 2.5 mg increments no sooner than every four weeks, to a maximum of 15 mg weekly. That schedule is a clinical decision, not a shopping decision. Nobody at the storefront adjusts your dose, calls you at week four, or slows your titration when nausea bites. Your prescriber owns that entirely, so agree a follow-up rhythm before your first order and put it in the diary.
Read the current FDA-approved labelling for your exact presentation on DailyMed FDA labelling, and our Tirzepatide Dosing And Side Effects notes for plain-language context.
Side effects, warnings and who should not take it
The common effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, stomach pain and injection site reactions. Most ease as the body adjusts, and most get worse right after a dose increase.
The serious ones deserve attention before you buy. Tirzepatide carries a boxed warning for thyroid C-cell tumors seen in rodents, and it is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pancreatitis, gallbladder disease, severe dehydration with kidney injury, and worsening diabetic retinopathy are all described in the labelling. Low blood sugar becomes a real risk when the drug is combined with insulin or a sulfonylurea, which needs a dose plan from your prescriber. Delayed stomach emptying also matters before surgery or sedation, so tell your anesthesia team.
Call a clinician promptly for severe or lasting abdominal pain, persistent vomiting, signs of dehydration, a lump or swelling in the neck, hoarseness, or trouble swallowing.
What this track costs here, and what it avoids
At $299 to $449 for a one-month supply on self-pay, this is brand-name product from the manufacturer. That sidesteps the compounded GLP-1 market, where the FDA has set out its concerns about unapproved copies in its guidance on unapproved GLP-1 drugs for weight loss. If provenance is what worries you, buying the approved product from the company that makes it is about as direct as the supply chain gets.
Retail collection widened the route further: Walmart’s newsroom announced an in-store pick-up option for Zepbound at direct-to-consumer pricing in October 2025, which suits anyone who dislikes waiting for a cold-chain delivery at home.
Who this track suits
It works for someone with an engaged prescriber, a fixed medicine choice and a cash budget. It works poorly for someone who wants weight management delivered as a program, with labs ordered, side effects triaged and doses adjusted by the same organisation that ships the box. If that is what you want, compare full-service options on our GLP-1 Telehealth Comparison instead.
Foundayo at $149 a month
Foundayo sits in the self-pay catalogue at a lower price point than Zepbound, listed from $149 for a one-month supply. It has drawn steady search interest alongside Zepbound since it appeared on the platform.
Before ordering, open the FDA-approved labelling and the medication guide for it. Three things decide whether $149 is a good number for you: the approved indication, the starting dose, and how quickly the dose is meant to escalate. A low monthly price on a starting dose is not the same as a low monthly price on a maintenance dose. Ask your prescriber to confirm which strength that listing covers and what the price becomes if you titrate upward.
Humalog and the insulin track
The $35 listing
Humalog, insulin lispro, is a rapid-acting mealtime insulin, listed from $35 for a one-month supply on self-pay. For people who fall through the cracks between plans, or who face a high deductible early in the year, that figure is genuinely useful. It is also the clearest example of what this storefront is good at: a published number, no membership, no negotiation.
Using insulin safely without a care team attached
Insulin is unforgiving of guesswork. Hypoglycemia is the main risk, and it becomes more likely with missed meals, alcohol, extra activity or a dose change. Never adjust units on your own because you switched supply route. Keep a glucose meter or sensor in play, keep fast-acting carbohydrate on hand, and never share a pen or needle even after changing the tip. Storage rules and expiry after first use are on the label and matter for potency.
Patient-facing background on insulin use and monitoring is set out by NIDDK diabetes information. Your A1c reviews and dose changes still belong with the clinician who knows your history.
Migraine and the rest of the catalogue
Lilly launched the platform in January 2024 as a digital experience for people living with obesity, migraine and diabetes, according to its own Lilly investor announcement. The catalogue has grown since, but the boundary has not moved: it stocks Lilly products only.
That boundary is the quiet limitation. If your migraine preventive is not working, this route cannot move you to another company’s medicine. Neither can it move you from one manufacturer’s GLP-1 to another. Pricing also varies by medicine rather than following one house rate, so confirm the figure for your specific drug rather than assuming the weight-loss or insulin pricing carries across. Background on individual drugs sits in Our Medication Guides.
Who prescribes, and how the care gap works
Two routes exist. Your existing clinician writes the prescription and sends it to the dispensing pharmacy named for your medicine, which is the cleanest path if you already have a relationship. Or you use an independent telehealth provider the platform connects you with, which involves a separate company, a separate fee and a separate record.
Either way, the manufacturer is not your prescriber and does not supervise your treatment. That is not a scandal, it is the design, and it explains most of what this platform does and does not do well. It also means nobody in the ordering chain is watching for the drug interaction, the missed lab, or the side effect you decided to tolerate.
| Track | What the medicine is for | Who writes the prescription | Follow-up inside the price | Monitoring you arrange yourself |
|---|---|---|---|---|
| Zepbound | Chronic weight management; obstructive sleep apnea in adults with obesity | Your own clinician or an independent telehealth partner | None | Weight, blood pressure, glucose if diabetic, symptoms of pancreatitis or gallbladder disease |
| Foundayo | Confirm the approved indication on the FDA labelling before ordering | Your own clinician or an independent telehealth partner | None | As your prescriber directs |
| Humalog | Blood sugar control in diabetes | Your own clinician or an independent telehealth partner | None | Glucose logs, a hypoglycemia plan, A1c reviews |
| Migraine medicines | Migraine, one of the launch categories | Your own clinician or an independent telehealth partner | None | Headache diary and response review with your clinician |
Ordering it, step by step
Step 1: Confirm the medicine and the number
Find your medicine on the site and read the self-pay figure for a one-month supply of the strength you actually take. Screenshot it.
Step 2: Get a valid prescription
Ask your own clinician first. Prescription medicines still require an evaluation by a licensed prescriber, and using the manufacturer’s storefront changes nothing about that. If you have no prescriber, the independent telehealth route exists, at its own cost.
Step 3: Route the prescription to the named pharmacy
Prescriptions go to licensed third-party dispensing pharmacies rather than to Lilly itself. Give your prescriber the exact pharmacy name for your medicine, because sending it to a local store by habit stalls the order.
Step 4: Create the pharmacy account
You register on the portal that pharmacy uses, verify identity and confirm the delivery address. Public sign-in pages exist at the Prescryptive LillyDirect portal and the Fuze Health sign-in page, and Gifthealth appears widely in patient searches. Note which one is yours on day one.
Step 5: Pay and choose fulfilment
You pay the listed cash price by card. Delivery is standard, and Walmart pick-up has been announced for Zepbound at direct-to-consumer pricing through Walmart’s newsroom announcement.
Step 6: Diary the refill and the follow-up
Set a reminder about a week before you run out, and a separate one for the prescriber review that keeps the prescription alive.
On coverage across the country, shipping and the telehealth partners both depend on pharmacy and clinician licensing in your state. Confirm your address is served before you build a budget around a figure.
Refills, portals and reaching a human
Support is the softest part of the experience. Contact does not sit with the manufacturer: it sits with whichever dispensing pharmacy holds your prescription, and those partners have their own numbers, hours and portals. The sign-in pages list a toll-free support line, which is worth saving to your phone under the pharmacy’s name rather than under Lilly’s.
Refill friction shows up clearly in what people search for: which portal to log into, which pharmacy to call, whether a prescriber sent the script, and when a refill releases. None of that is a safety problem. It is the ordinary cost of a multi-partner supply chain, and it lands on the patient rather than on a care coordinator.
Two habits reduce the pain. Keep one written note with the pharmacy name, portal URL and phone number. And when a refill is late, contact the dispensing pharmacy first, then your prescriber, in that order.
Privacy and what a drugmaker learns about you
A manufacturer running its own storefront raises a fair question about data. The account you create usually lives with the dispensing pharmacy or its technology partner, not with Lilly, and that entity may control the health record attached to your order.
Read the privacy notice on the portal you actually land in, and look for four things: what the intake collects, whether the entity is a HIPAA covered entity or a consumer app operating under commercial privacy rules, what is shared with the manufacturer in identifiable form, and how to request deletion. Marketing consent is the one to read twice, because a storefront and a brand-marketing operation are close neighbours.
Trust and safety record
The strongest signals here are structural. The products are brand-name and FDA-approved, made by the company selling them, which removes the sourcing questions that hang over compounded copies. Prices are published per medicine, which is more transparency than most telehealth brands offer. Dispensing is handled by licensed pharmacies rather than by an unnamed fulfilment partner.
The gaps are equally plain. We found no LegitScript certification for the platform, and no Surescripts certification attached to it either. Because the manufacturer provides no clinicians, there is also no prescriber roster to inspect, no titration protocol published as a standard of care, and no lab requirement built into the purchase. Refund and return terms for prescription medicines are set by the dispensing pharmacy, so read them on that pharmacy’s site rather than assuming a consumer-retail return policy applies.
You can verify certification status yourself through the LegitScript certification lookup, and see how we weight these signals in How We Score Providers.
Who gets the most from this, and who should look elsewhere
Best served: people who already have a diagnosis and a prescriber, who know exactly which Lilly medicine they take, and who are paying cash because coverage denied the drug or the deductible has not been met. Also served well: insulin users needing a predictable $35 monthly figure, and anyone who wants brand-name product rather than a compounded alternative.
Look elsewhere if you want one organisation to handle the consult, the labs, the titration and the shipment, or if your plan already covers the medicine at a lower copay. Look elsewhere too if you may need to switch molecules or manufacturers, because this catalogue cannot follow you there. Browsing the wider field starts in our Telehealth Provider Directory.
Questions worth asking before your first order
Before Your First LillyDirect Order
- Confirm which strength the listed price covers and what the next dose up costs
- Identify which dispensing pharmacy will fill your medicine and save its direct phone number
- Ask your prescriber which labs are needed before starting and how often after
- Agree a follow-up schedule for dose changes or side effects before the first shipment
- Check whether your HSA or FSA card is accepted for the cash purchase
- Verify your address is served by the pharmacy and telehealth partner in your state
- Which strength does the listed price cover, and what does the next dose up cost per month?
- Which pharmacy will dispense my medicine, and what is its direct phone number?
- What labs do you want before I start, and how often after that?
- How will we handle nausea or a stalled response without changing my dose by guesswork?
- If I am switching from another service, how do I move my records and avoid a gap in supply?
- What is the pharmacy’s policy if a shipment arrives damaged or warm?
If you are leaving a subscription program, ask that provider when cancellation takes effect and whether a final charge is already committed. Then run twelve months of cash pricing against your plan’s copay before you switch, using our Free Savings Report as a starting point.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Reputation check
The attributable public record is corporate and consistent. Lilly described the service in its own January 2024 investor release as a digital healthcare experience for people living with obesity, migraine and diabetes. Walmart’s October 2025 newsroom post confirmed retail pick-up for Zepbound at direct-to-consumer pricing. National consumer coverage, including a US News explainer on using the platform, describes the same structure we found: valid prescriptions routed to licensed third-party pharmacies, with care from independent clinicians rather than from the manufacturer.
Public sentiment skews operational rather than clinical. The recurring questions are about logins, which pharmacy holds the script, how a prescriber sends it, and when refills release, which points squarely at the multi-partner handoff as the friction point. Pricing transparency draws consistently positive comment, because the figures are published per medicine instead of hidden behind an intake form. We found no LegitScript listing for the platform, and no app-store or BBB profile we could attribute to it specifically rather than to the parent company. Patient reviews published on this site are moderated, incentivised reviews are always labeled, and sponsored placement, where it appears, is labeled and never affects scores or rankings. Read this LillyDirect review alongside those member reviews rather than instead of them.
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.